{"id":49770,"date":"2021-03-09T11:20:13","date_gmt":"2021-03-09T10:20:13","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=49770"},"modified":"2021-03-09T14:21:12","modified_gmt":"2021-03-09T13:21:12","slug":"nafld-putting-the-spotlight-on-a-hidden-public-health-challenge","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/","title":{"rendered":"NAFLD: Putting the spotlight on a hidden public health challenge"},"content":{"rendered":"<p><span style=\"font-weight: 400\">\u201cNon-alcoholic fatty liver disease [NAFLD] is an illness many of us have never heard of but it is much more common than cirrhosis and far more baffling.\u201d These are the words of author Bill Bryson in his book <\/span><i><span style=\"font-weight: 400\">The Body<\/span><\/i><span style=\"font-weight: 400\"> and he is right. It seems implausible that an illness which affects an estimated 2 billion people globally, causes a substantial burden of ill health, and has <\/span><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/liv.14825\"><span style=\"font-weight: 400\">wide ranging social and economic implications<\/span><\/a><span style=\"font-weight: 400\">, still remains as obscure as NAFLD is today. In fact, this obscurity is not limited to the general public, but also applies to many healthcare professionals and the wider global health community.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">NAFLD is often referred to as the hepatic manifestation of metabolic syndrome due to its close association with obesity and other metabolic conditions, and its complex bidirectional relationship with insulin resistance and type 2 diabetes mellitus. Yet, unlike other highly prevalent non-communicable diseases (NCDs) such as diabetes, heart disease, and obesity, NAFLD is yet to be widely recognised as a major public health challenge worthy of attention.<\/span><\/p>\n<p><span style=\"font-weight: 400\">NAFLD is entirely <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31518646\/\"><span style=\"font-weight: 400\">absent from national health strategies<\/span><\/a><span style=\"font-weight: 400\"> and few countries have specific clinical guidance for the management of the condition. Despite the close association with other major non communicable diseases (NCDs), and the overlapping approaches required to address these conditions, NAFLD is also not explicitly mentioned in key global health documents on the prevention and control of NCDs.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">Over the past 24 months, the <\/span><a href=\"https:\/\/easl-ilf.org\/\"><span style=\"font-weight: 400\">EASL International Liver Foundation<\/span><\/a><span style=\"font-weight: 400\"> (EILF) has been collaborating with a wide range of partners, from clinicians and academics, to policy-makers and industry, to shine a <\/span><a href=\"https:\/\/www.wiltonpark.org.uk\/wp-content\/uploads\/2021\/02\/WP1736V3-Report.pdf\"><span style=\"font-weight: 400\">spotlight on NAFLD<\/span><\/a><span style=\"font-weight: 400\">. As part of these efforts, EILF recently engaged the Economist Intelligence Unit to hold a workshop series <\/span><a href=\"https:\/\/eiuperspectives.economist.com\/healthcare\/nafld-sounding-alarm-global-public-health-challenge\"><i><span style=\"font-weight: 400\">NAFLD: Sounding the alarm on a global public health challenge<\/span><\/i><\/a><span style=\"font-weight: 400\"> with experts from Asia, Latin America, and the Middle East. During 12 workshops throughout 2020, more than 50 experts, ranging from liver disease and diabetes specialists, to primary care providers and public health leaders, explored a diverse range of topics, from improving the diagnosis and care of affected populations to broader public health responses and integration of NAFLD within the NCD agenda. The outcome of these discussions has been distilled into a global call to action covering five key areas.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Several cross-cutting themes emerged throughout the series. The first recognised the critical importance of collaboration between key stakeholders including professional associations, care providers, patient groups, or policy actors.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">People living with NAFLD access care across different parts of healthcare systems, with many requiring services for multiple comorbid conditions. The efficient and effective flow of information and resources between key stakeholders, including clinical teams and patients, is critical. Yet, in many settings there remain silos that inhibit joined-up health system responses. Ultimately what is required is a reorientation of health systems. The challenges and solutions here are not exclusive to NAFLD. There is, however, a compelling case for the NAFLD community to work alongside others, especially those who focus on metabolic disease management, to lead this process and envisage what is required to design and deliver patient-centric healthcare systems fit for dealing with the 21<\/span><span style=\"font-weight: 400\">st<\/span><span style=\"font-weight: 400\"> century\u2019s major health issues, namely NCDs.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">The second emerging theme focused on the need to be bold and ambitious when plotting the course for NAFLD. Like other NCDs, addressing NAFLD will require <\/span><a href=\"https:\/\/www.nature.com\/articles\/s41575-020-0315-7\"><span style=\"font-weight: 400\">comprehensive public health responses<\/span><\/a><span style=\"font-weight: 400\"> that address not only the immediate health needs of affected populations, but also the underlying and basic influences that give rise to the condition. The NCD community has been criticised for having a singular focus on <\/span><a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(19)31038-4\/fulltext\"><span style=\"font-weight: 400\">Sustainable Development Goal 3<\/span><\/a><span style=\"font-weight: 400\">, \u201censure healthy lives and promote well-being for all at all ages\u201d, and not looking at the multisectoral, whole-of-society responses that can deliver a significant and sustained impact.\u00a0 The liver health community must take heed of this and consider how to engage broadly across sectors and disciplines as it sets out the vision of addressing NAFLD. This will have to start with a moment of reflection to consider the liver health landscape and consult with others in different sectors and disciplines to identify opportunities for collaboration and integration.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">We remain at ground zero in the public health response to NAFLD. We would urge the global health community to see this blank canvas as an opportunity to leverage its collective knowledge to develop innovative approaches that can benefit not only people living with NAFLD, but the NCD community as a whole. We are in no doubt that transforming NAFLD from a hidden challenge to a public health priority will be challenging, requiring sustained commitment from clinicians, patients, and policy makers alike. We are, however, inspired by the recent workshop series and the vibrant community ready to lead this charge.\u00a0<\/span><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Jeffrey V Lazarus<\/strong> is head of the Health Systems Research Group at the Barcelona Institute for Global Health (ISGlobal), an associate professor at the Faculty of Medicine, University of Barcelona, Barcelona, Spain, and vice-chair of the EASL International Liver Foundation, Geneva, Switzerland. <\/span><a href=\"https:\/\/twitter.com\/JVLazarus\"><span style=\"font-weight: 400\">@JVLazarus<\/span><\/a><\/em><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Henry E Mark<\/strong> is a Programme Manager with the EASL International Liver Foundation, Geneva, Switzerland. @<\/span><a href=\"https:\/\/twitter.com\/HenryEMark\"><span style=\"font-weight: 400\">HenryEMark<\/span><\/a><\/em><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Massimo Colombo<\/strong> is Chairman of the EASL International Liver Foundation, Geneva, Switzerland and Director Liver Center IRCCS San Raphael Hospital, Milan, Italy. <a href=\"https:\/\/twitter.com\/mcolombo46?lang=en\">@mcolombo46<\/a><\/span><\/em><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Philip N Newsome<\/strong> is Director of Research and Knowledge Transfer for the College of Medical &amp; Dental Sciences and Director of the Centre for Liver and Gastrointestinal Research at the University of Birmingham, and the Secretary General of the European Association for the Study of the Liver (EASL) <\/span><a href=\"https:\/\/twitter.com\/phil_newsome7\"><span style=\"font-weight: 400\">@phil_newsome7<\/span><\/a><\/em><\/p>\n<p><em><span class=\"il\"><strong>Competing interests<\/strong>: <\/span><span class=\"il\">Jeffrey<\/span>\u00a0V\u00a0<span class=\"il\">Lazarus<\/span>\u00a0reports research grants from Genfit, Gilead and Intercept, outside of the work discussed here. Massimo Colombo reports personal fees from Intercept, Exelyxis, COST, and Target HCC, outside of the work discussed here. Phil Newsome\u00a0reports receiving grant support from Pharmaxis, Boehringer Ingelheim and Novo Nordisk, donated supplies from Echosens, and consulting fees, paid to the University of Birmingham, from Bristol-Myers Squibb, Gilead, Intercept, Novo Nordisk, Pfizer, and Poxel, outside of the work discussed here.\u00a0Henry Mark declares no competing interests relevant to this article.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cNon-alcoholic fatty liver disease [NAFLD] is an illness many of us have never heard of but it is much more common than cirrhosis and far more baffling.\u201d These are the [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":66,"featured_media":49771,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5749],"tags":[],"class_list":["post-49770","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patient-perspectives"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NAFLD: Putting the spotlight on a hidden public health challenge - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NAFLD: Putting the spotlight on a hidden public health challenge - The BMJ\" \/>\n<meta property=\"og:description\" content=\"\u201cNon-alcoholic fatty liver disease [NAFLD] is an illness many of us have never heard of but it is much more common than cirrhosis and far more baffling.\u201d These are the [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-09T10:20:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-09T13:21:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/03\/non_alcoholic_fatty_liver_disease.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"julietwalker\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"julietwalker\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/\"},\"author\":{\"name\":\"julietwalker\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/373707d32533c2cbca204980b8cd3493\"},\"headline\":\"NAFLD: Putting the spotlight on a hidden public health challenge\",\"datePublished\":\"2021-03-09T10:20:13+00:00\",\"dateModified\":\"2021-03-09T13:21:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/\"},\"wordCount\":1004,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/03\\\/non_alcoholic_fatty_liver_disease.jpg\",\"articleSection\":[\"Patient and public perspectives\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/\",\"name\":\"NAFLD: Putting the spotlight on a hidden public health challenge - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/03\\\/non_alcoholic_fatty_liver_disease.jpg\",\"datePublished\":\"2021-03-09T10:20:13+00:00\",\"dateModified\":\"2021-03-09T13:21:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/03\\\/non_alcoholic_fatty_liver_disease.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/03\\\/non_alcoholic_fatty_liver_disease.jpg\",\"width\":540,\"height\":350,\"caption\":\"Light micrograph of liver cells showing vacuoles in their nuclei (dark purple). Nuclear vacuolation is a characteristic histological feature of non-alcoholic fatty liver disease (NAFLD) that can help distinguish it from alcohol-induced liver disease. Stained with haematoxylin and eosin. Magnification: x900 when printed at 10 centimetres across.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/03\\\/09\\\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NAFLD: Putting the spotlight on a hidden public health challenge\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/373707d32533c2cbca204980b8cd3493\",\"name\":\"julietwalker\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g\",\"caption\":\"julietwalker\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/julietwalker\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NAFLD: Putting the spotlight on a hidden public health challenge - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/","og_locale":"en_US","og_type":"article","og_title":"NAFLD: Putting the spotlight on a hidden public health challenge - The BMJ","og_description":"\u201cNon-alcoholic fatty liver disease [NAFLD] is an illness many of us have never heard of but it is much more common than cirrhosis and far more baffling.\u201d These are the [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2021-03-09T10:20:13+00:00","article_modified_time":"2021-03-09T13:21:12+00:00","og_image":[{"width":540,"height":350,"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/03\/non_alcoholic_fatty_liver_disease.jpg","type":"image\/jpeg"}],"author":"julietwalker","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"julietwalker","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/"},"author":{"name":"julietwalker","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/373707d32533c2cbca204980b8cd3493"},"headline":"NAFLD: Putting the spotlight on a hidden public health challenge","datePublished":"2021-03-09T10:20:13+00:00","dateModified":"2021-03-09T13:21:12+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/"},"wordCount":1004,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/03\/non_alcoholic_fatty_liver_disease.jpg","articleSection":["Patient and public perspectives"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/","url":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/","name":"NAFLD: Putting the spotlight on a hidden public health challenge - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/03\/non_alcoholic_fatty_liver_disease.jpg","datePublished":"2021-03-09T10:20:13+00:00","dateModified":"2021-03-09T13:21:12+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/03\/non_alcoholic_fatty_liver_disease.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/03\/non_alcoholic_fatty_liver_disease.jpg","width":540,"height":350,"caption":"Light micrograph of liver cells showing vacuoles in their nuclei (dark purple). Nuclear vacuolation is a characteristic histological feature of non-alcoholic fatty liver disease (NAFLD) that can help distinguish it from alcohol-induced liver disease. Stained with haematoxylin and eosin. Magnification: x900 when printed at 10 centimetres across."},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/03\/09\/nafld-putting-the-spotlight-on-a-hidden-public-health-challenge\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"NAFLD: Putting the spotlight on a hidden public health challenge"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/373707d32533c2cbca204980b8cd3493","name":"julietwalker","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g","caption":"julietwalker"},"url":"https:\/\/blogs.bmj.com\/bmj\/author\/julietwalker\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/49770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/66"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=49770"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/49770\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/49771"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=49770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=49770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=49770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}